Full Description
The new millennium has carried several challenges for patent law. This up-to-date book provides readers with an important overview of the most critical issues patent law is still facing today at the beginning of the twenty first century, on both sides of the Atlantic.
New technological sectors have emerged, each one with its own features with regard to innovation process and pace. From the most controversial cases in biotech to the most recent decisions in the field of software and business methods patent, patent law has tried to stretch its boundaries in a way to accommodate such new and controversial subject matters into its realm.
Biotechnology and Software Patent Law will strongly appeal to postgraduate students specializing in IP law, international law, commercial and business law, competition law as well as IP scholars, academics and lawyers.
Contributors: S.D. Anderman, R.B. Bakels, S.J.R. Bostyn, D.L. Burk, V. Di Cataldo, V. Falce, C. Geiger, R.M. Hilty, C.M. Holman, M.A. Lemley, A. Ottolia, J. Pila, J.R. Thomas, P.L.C. Torremans
Contents
Contents:
Introduction
Emanuela Arezzo and Gustavo Ghidini
PART I: GENERAL THEMES IN PATENT LAW
1. Tailoring Patents to Different Industries
Dan L. Burk and Mark A. Lemley
2. Innovation in the New Technological Industries: Looking for a Consistent Cooperative Model
Valeria Falce
3. The Future of the Requirement for an Invention: Inherent Patentability as a Pre- and Post-Patent Determinant
Justine Pila
4. The Experimental Use of the Patented Invention: A Free Use or an Infringing Use?
Vincenzo Di Cataldo
5. Patents and Competition Law: Some Features of the New Interface
Steven D. Anderman
PART II: EMERGING THEMES IN INFORMATION TECHNOLOGIES
6. Are Software Patents Something Special?
Reinier B. Bakels
7. Towards a New Instrument of Protection for Software in the EU? Learning the Lessons from the Harmonization Failure of Software Patentability
Reto M. Hilty and Christophe Geiger
8. Patent Governance in the United States: Lessons from Bilski v. Kappos
John R. Thomas
PART III: EMERGING THEMES IN THE BIOTECH INDUSTRIES
9. A Decade After the Birth of the Biotech Directive: Was it Worth the Trouble?
Sven J.R. Bostyn
10. Gene Patents Under Fire: Weighing the Costs and Benefits
Christopher M. Holman
11. Patentability of Human Stem Cell or Synthetic Biology Based Inventions
Paul L.C. Torremans
12. Moral Limits to Biotech Patents in Europe: A Quest for Higher Harmonization
Andrea Ottolia
Index
